21(R)-Hydroxy Montelukast (CAS 184763-26-6)

21(R)-Hydroxy Montelukast is a chemically modified derivative of montelukast, a leukotriene receptor antagonist, primarily distinguished by its specific hydroxylation at the 21st carbon in the R configuration. This structural alteration significantly influences its interaction with leukotriene receptors, potentially altering its affinity or selectivity compared to its parent compound. In research applications, 21(R)-Hydroxy Montelukast serves as a tool for probing the biochemical pathways involved in leukotriene receptor signaling and regulation. Its unique properties enable scientists to dissect the nuanced mechanisms through which leukotrienes influence cellular responses, contributing to a deeper understanding of inflammatory processes at a molecular level. By offering a variant molecular structure, this compound aids in elucidating the role of specific leukotriene receptor subtypes in various signaling pathways, facilitating the exploration of their contributions to cellular and physiological responses in model organisms.